ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)

Clinical trial NCT05221372 · RECRUITING

Trial details

NCT number: NCT05221372
Sponsor: Erasmus Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Liquid Biopsy Tyrosine Kinase Inhibitor

Start date: 2017-02-02
Primary completion: 2031-01-01
Enrollment: 1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.